Industry News

BioLase, Auris to develop laser cataract-removal robot

BioLase and Auris Surgical Robotics have signed a letter of commitment to develop a cataract-removal robot, according to a news release. 

The robot will utilize BioLase’s patented WaterLase YSGG all-tissue atraumatic cutting technology mounted on a robotic operating system manufactured by Auris. 

The goal of the robot would be to improve the precision, safety and predictability of cataract-removal procedures, similar to the way other telerobotic systems have been used for procedures such as prostatectomy, fibroidectomy and knee hemi-arthroplasty, according to the release. 

The development is in the feasibility and prototyping phase, the release said.

BioLase and Auris Surgical Robotics have signed a letter of commitment to develop a cataract-removal robot, according to a news release. 

The robot will utilize BioLase’s patented WaterLase YSGG all-tissue atraumatic cutting technology mounted on a robotic operating system manufactured by Auris. 

The goal of the robot would be to improve the precision, safety and predictability of cataract-removal procedures, similar to the way other telerobotic systems have been used for procedures such as prostatectomy, fibroidectomy and knee hemi-arthroplasty, according to the release. 

The development is in the feasibility and prototyping phase, the release said.